Ignite Creation Date:
2024-05-06 @ 12:25 PM
Last Modification Date:
2024-10-26 @ 12:58 PM
Study NCT ID:
NCT03751761
Status:
COMPLETED
Last Update Posted:
2024-02-28
First Post:
2018-11-21
Brief Title:
GC 2nd Line DurvalumabMEDI4736Tremelimumab Plus Paclitaxel Study
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Organization Data
Organization:
Asan Medical Center
Class:
OTHER
Study ID:
AMC1803
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Asan Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Min-Hee Ryu
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Asan Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hallym University Medical Center | OTHER |
| Seoul National University Bundang Hospital | OTHER |